Mittie Doyle, Chief Medical Officer: Avalo Therapeutics AVTX Sell · Filed 06/25

Trade details

Type: Insider sale
Amount: $26,100
Shares · price: 1,450 sh · $18.00 a share
Held after: 51,776 sh
Stock: Avalo Therapeutics AVTX
Person: Mittie DoyleChief Medical Officer
Trade date: 26/06/23
Filed: 26/06/25
Days to filing: 2 days

Sold 2.7% of holdings

Share of holding sold: 2.7%

Avalo Therapeutics trades, last 26 weeks

What else happened in Avalo Therapeutics around then

Filed or reported within 30 days of the trade day · 05/24~07/23

Mittie Doyle's recent trades

Mittie DoyleChief Medical Officer
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$98.7K
5,037 sh
$98.7K
Filed 08/17
Traded 08/17
Mittie DoyleChief Medical Officer
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$12.4K
679 sh
$12.4K
Filed 08/10
Traded 08/10
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$10.9K
679 sh
$10.9K
Filed 06/01
Traded 05/28
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$56.3K
3,000 sh
$56.3K
Filed 05/19
Traded 05/15
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$952.8K
44,944 sh
$952.8K
Filed 05/07
Traded 05/06